H. Lundbeck AS (STU:LDBA) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 04, 2026)


STU:LDBA H. Lundbeck AS STU:LDBA
68 GF Score
Price €5.75
GF Value €6.12
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is H. Lundbeck AS Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

H. Lundbeck AS's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

STU:LDBA vs ZTS, UTHR, VTRS: Margin of Safety % (DCF Dividends Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

H. Lundbeck AS Margin of Safety % (DCF Dividends Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where H. Lundbeck AS's Margin of Safety % (DCF Dividends Based) falls into.


STU:LDBA
68GF Score
H. Lundbeck AS STU:LDBA
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is H. Lundbeck AS (STU:LDBA) Overvalued in 2026?

Based on GuruFocus' analysis, H. Lundbeck AS stock appears to be undervalued. The current stock price of €5.75 is trading 6% below its estimated GF Value™ of €6.12. GuruFocus considers H. Lundbeck AS to be Modestly Undervalued.

Key valuation signals for STU:LDBA:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: €6.12 vs. price of €5.75 (6% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the STU:LDBA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

H. Lundbeck AS Business Description

Address Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.
68GF Score

Get the complete analysis for STU:LDBA

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.75
Price
€6.12
GF Value